Investigational Drug Service (IDS)
The Investigational Drug Service (IDS) is a part of the Department of Pharmacy and was established in 1983. The IDS was created to comply with legal, university and sponsor requirements for research and to ensure safe and efficient investigational medication use. Further, IDS is tasked with meeting Joint Commission standards for investigational medication management.
The pharmacists and pharmacy technicians of the IDS are responsible for coordinating pharmacy involvement in investigational/clinical medication studies approved by the Biomedical Sciences Institutional Review Board (IRB), James Cancer IRB or an external IRB. Operational activities performed by IDS staff include medication acquisition, inventory management, investigational medication distribution and investigational medication accountability. Investigational medication supplies are handled and dispensed in accordance with applicable legal, institutional, professional and agreed upon sponsor requirements.
Currently, the IDS manages approximately 550 open trials. These trials range from phase 1 to phase 3 and include industry-sponsored, cooperative group and investigator-initiated trials. If you would like more information on services provided by the IDS or wish to request a budget for an upcoming study, please contact us at email@example.com. Please include a copy of the current protocol and pharmacy manual, if available, at the time of request.
Standard Operating Procedures (SOPs)